
|Articles|December 10, 2007
Latebreakers: Final DEA rule OKs multiple Schedule II Rxs
A final rule from the DEA allows doctors to give patients multiple prescriptions for up to a 90-day supply of Schedule II controlled substances.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Understanding the Criteria, Process for Rx-to-OTC Switches
2
Extreme Weather Disrupts Pharmacy Operations and Community Health Resilience
3
How Oral GLP-1 Medication Will Impact the Patient Medication Journey
4
Pro-Life Groups Calling for Immediate Government Action on Abortion Pills
5


















